Stimulation to Improve Memory
Launched by UNIVERSITY OF MICHIGAN · Mar 13, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Stimulation to Improve Memory," is exploring how different doses of a safe, non-invasive brain stimulation technique can help people with mild cognitive impairment (MCI) and Alzheimer's-type dementia. The research is aimed at understanding whether this stimulation can improve memory and cognitive function in individuals facing these challenges.
To participate, individuals must have a diagnosis of MCI or Alzheimer's dementia and be able to undergo an MRI scan safely, meaning they don't have any metal implants in their upper body or head. Participants should also be stable on their current medications for at least four weeks before joining the study. The trial is currently recruiting and is open to all genders. If you or a loved one meet these criteria, you could help contribute to important research that may lead to better treatments for memory-related conditions. Participants can expect to receive brain stimulation in a supervised setting and will be closely monitored throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosis of Mild Cognitive Impairment (MCI) or dementia of the Alzheimer's type (DAT)
- • 2. Must be MRI compatible, criteria that also apply for High Definition transcranial direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants in the upper body or head)
- • 3. Stable on relevant medications for at least 4 weeks prior to study enrollment
- Exclusion Criteria:
- • 1. Certain neurological diseases
- • 2. Certain psychiatric conditions
- • 3. Severe sensory impairment
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Benjamin Hampstead, PhD
Principal Investigator
Associate Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials